A detailed history of Strs Ohio transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Strs Ohio holds 38,600 shares of NUVB stock, worth $90,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,600
Previous 34,700 11.24%
Holding current value
$90,324
Previous $126,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$2.58 - $3.69 $10,062 - $14,391
3,900 Added 11.24%
38,600 $112,000
Q1 2024

May 13, 2024

SELL
$1.46 - $3.97 $3,212 - $8,734
-2,200 Reduced 5.96%
34,700 $126,000
Q4 2021

Jan 24, 2022

BUY
$7.75 - $10.05 $167,400 - $217,080
21,600 Added 141.18%
36,900 $313,000
Q3 2021

Oct 22, 2021

BUY
$7.78 - $10.0 $55,238 - $71,000
7,100 Added 86.59%
15,300 $152,000
Q2 2021

Jul 26, 2021

BUY
$9.22 - $14.48 $75,604 - $118,736
8,200 New
8,200 $76,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.